Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Nov;68(5):1374–1377. doi: 10.1172/JCI110386

Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.

P H Stern, A B Taylor, N H Bell, S Epstein
PMCID: PMC370935  PMID: 6975284

Abstract

The effects of vitamin D, 2.5 mg (100,000 U)/d for 4 d, on serum calcium, serum 25-hydroxyvitamin D (25-OHD) and serum 1 alpha, 25-dihydroxyvitamin D (1 alpha, 25(OH)2D) were compared in 24 normal adults and 12 normal children. The daily dose of vitamin D was 1,500 U/kg body wt in children weighing less than 45 kg. Vitamin D increased mean serum calcium from 9.5 +/- 0.1 to 9.8 +/- 0.1 mg/dl (P less than 0.05), increased mean serum phosphorus from 4.6 +/- 0.1 to 5.0 +/- 0.1 mg/dl (P less than 0.01), increased mean serum 25-OHD from 25 +/- 3 to 34 +/- 4 ng/ml (P less than 0.001), and increased mean serum 1 alpha, 25(OH)2D from 34 +/- 3 to 42 +/- 4 pg/ml (P less than 0.02) in children. In contrast, vitamin D increased mean serum 25-OHD from 18 +/- 2 to 39 +/- 6 ng/ml (P less than 0.001) and did not change mean serum calcium (9.4 +/- 0.1 vs. 9.5 +/- 0.1 mg/dl), mean serum phosphorus (4.0 +/- 0.1 vs. 4.1 +/- 0.1 mg/dl), or mean serum 1 alpha, 25(OH)2D (31 +/- 2 vs. 29 +/- 3 pg/ml) in adults. Mean serum 1 alpha, 25(OH)2D was significantly higher after vitamin D in children than in adults (P less than 0.02). These results provide evidence that circulating 1 alpha, 25(OH)2D is not as tightly regulated in children as it is in adults. This difference in regulation could account in part for the higher values for serum 1 alpha, 25(OH)2D observed in children.

Full text

PDF
1374

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baginski E. S., Marie S. S., Clark W. L., Zak B. Direct microdetermination of serum calcium. Clin Chim Acta. 1973 Jun 14;46(1):49–54. doi: 10.1016/0009-8981(73)90101-0. [DOI] [PubMed] [Google Scholar]
  2. Barbour G. L., Coburn J. W., Slatopolsky E., Norman A. W., Horst R. L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med. 1981 Aug 20;305(8):440–443. doi: 10.1056/NEJM198108203050807. [DOI] [PubMed] [Google Scholar]
  3. Bartels H., Böhmer M. Eine Mikromethode zur Kreatininbestimmung. Clin Chim Acta. 1971 Mar;32(1):81–85. doi: 10.1016/0009-8981(71)90467-0. [DOI] [PubMed] [Google Scholar]
  4. Bell N. H., Stern P. H., Pantzer E., Sinha T. K., DeLuca H. F. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest. 1979 Jul;64(1):218–225. doi: 10.1172/JCI109442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Belsey R. E., DeLuca H. F., Potts J. T., Jr A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J Clin Endocrinol Metab. 1974 Jun;38(6):1046–1051. doi: 10.1210/jcem-38-6-1046. [DOI] [PubMed] [Google Scholar]
  6. Chesney R. W., Mazess R. B., Hamstra A. J., DeLuca H. F., O'Reagan S. Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids. Lancet. 1978 Nov 25;2(8100):1123–1125. doi: 10.1016/s0140-6736(78)92277-8. [DOI] [PubMed] [Google Scholar]
  7. Chesney R. W., Rosen J. F., Hamstra A. J., DeLuca H. F. Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders. Am J Dis Child. 1980 Feb;134(2):135–139. doi: 10.1001/archpedi.1980.02130140009004. [DOI] [PubMed] [Google Scholar]
  8. Chipman J. J., Zerwekh J., Nicar M., Marks J., Pak C. Y. Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol Metab. 1980 Aug;51(2):321–324. doi: 10.1210/jcem-51-2-321. [DOI] [PubMed] [Google Scholar]
  9. Connerty H. V., Briggs A. R. Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol. 1966 Mar;45(3):290–296. doi: 10.1093/ajcp/45.3.290. [DOI] [PubMed] [Google Scholar]
  10. Gertner J. M., Horst R. L., Broadus A. E., Rasmussen H., Genel M. Parathyroid function and vitamin D metabolism during human growth hormone replacement. J Clin Endocrinol Metab. 1979 Aug;49(2):185–188. doi: 10.1210/jcem-49-2-185. [DOI] [PubMed] [Google Scholar]
  11. HENNEMAN P. H., FORBES A. P., MOLDAWER M., DEMPSEY E. F., CARROLL E. L. Effects of human growth hormone in man. J Clin Invest. 1960 Aug;39:1223–1238. doi: 10.1172/JCI104138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hahn T. J., Halstead L. R., Baran D. T. Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 1981 Jan;52(1):111–115. doi: 10.1210/jcem-52-1-111. [DOI] [PubMed] [Google Scholar]
  13. Haussler M. R., Hughes M. R., McCain T. A., Zerwekh J. E., Brumbaugh P. F., Jubiz W., Wasserman R. H. 1,25-Dihydroxyvitamin D3: mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside from Solanum malacoxylon. Calcif Tissue Res. 1977 May;22 (Suppl):1–18. doi: 10.1007/BF02064033. [DOI] [PubMed] [Google Scholar]
  14. Lund B., Clausen N., Lund B., Andersen E., Sørensen O. H. Age-dependent variations in serum 1,25-dihydroxyvitamin D in childhood. Acta Endocrinol (Copenh) 1980 Jul;94(3):426–429. doi: 10.1530/acta.0.0940426. [DOI] [PubMed] [Google Scholar]
  15. Plotnick L. P., Thompson R. G., Kowarski A., de Lacerda L., Migeon C. J., Blizzard R. M. Circadian variation of integrated concentration of growth hormone in children and adults. J Clin Endocrinol Metab. 1975 Feb;40(2):240–247. doi: 10.1210/jcem-40-2-240. [DOI] [PubMed] [Google Scholar]
  16. Seino Y., Shimotsuji T., Yamaoka K., Ishida M., Ishii T., Matsuda S., Ikehara C., Yabuuchi H., Dokoh S. Plasma 1,25-dihydroxyvitamin D concentrations in cords, newborns, infants, and children. Calcif Tissue Int. 1980;30(1):1–3. doi: 10.1007/BF02408599. [DOI] [PubMed] [Google Scholar]
  17. Stern P. H., De Olazabal J., Bell N. H. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest. 1980 Oct;66(4):852–855. doi: 10.1172/JCI109924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wiske P. S., Epstein S., Bell N. H., Queener S. F., Edmondson J., Johnston C. C., Jr Increases in immunoreactive parathyroid hormone with age. N Engl J Med. 1979 Jun 21;300(25):1419–1421. doi: 10.1056/NEJM197906213002506. [DOI] [PubMed] [Google Scholar]
  19. Zerwekh J. E., Pak C. Y., Kaplan R. A., McGuire J. L., Upchurch K., Breslau N., Johnson R., Jr Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J Clin Endocrinol Metab. 1980 Aug;51(2):381–386. doi: 10.1210/jcem-51-2-381. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES